# A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

> **NCT03493061** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 60 (actual)

## Conditions studied

- Colo-rectal Cancer
- Liver Metastases

## Interventions

- **DRUG:** Irinotecan
- **DRUG:** Oxaliplatin
- **DRUG:** Floxuridine

## Key facts

- **NCT ID:** NCT03493061
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-01
- **Primary completion:** 2020-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493061, "A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03493061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*